The presence of multiple chiral centres in a molecule adds a layer of complexity to its stereochemistry and optical activity. When a molecule has more than one chiral centre, the number of possible stereoisomers increases geometrically, leading to a variety of enantiomers and diastereomers. Diastereomers are stereoisomers that are not mirror images of each other and usually have different physical and chemical properties. Each pair of enantiomers will still exhibit optical activity, rotating plane-polarised light in opposite directions, but the overall optical activity of the molecule depends on the cumulative effect of all chiral centres. In some cases, the rotations caused by individual chiral centres can cancel each other out, leading to a meso compound, which is optically inactive despite having chiral centres. This is due to an internal plane of symmetry that allows for superposition of mirror images. Therefore, the overall optical activity of a molecule with multiple chiral centres is a complex interplay of the contributions from each chiral centre, and it cannot be easily predicted without specific configurational and conformational information.

Yes, molecules without carbon atoms can indeed be chiral. Chirality is not restricted to carbon-containing compounds; it can arise in any molecule that cannot be superimposed on its mirror image, regardless of the atoms involved. A notable example is the molecule of sulfur dichloride fluoride (SCl2F). In this molecule, the sulfur atom is bonded to two chlorine atoms and one fluorine atom, creating a trigonal pyramidal shape due to the lone pair on the sulfur atom. This geometry prevents the molecule from being superimposable on its mirror image, making it chiral. Such cases highlight the versatility and ubiquity of chirality in chemistry, extending beyond the traditional realm of organic compounds with carbon-based chiral centres. This broadens the scope of stereochemistry, encompassing a wide range of inorganic and organometallic compounds that exhibit chirality due to their spatial arrangements.

Chirality in macromolecules, especially proteins, is a critical aspect of their structure and function. Proteins are composed of amino acids, most of which are chiral themselves, existing predominantly in the L-configuration in nature. This inherent chirality of amino acids translates into the higher-order structures of proteins, influencing their folding, shape, and interaction with other biomolecules. The three-dimensional conformation of proteins is essential for their biological activity, including enzyme catalysis, signal transduction, and molecular recognition processes. The specificity of enzyme-substrate interactions, for example, is largely due to the chirality of both the enzyme's active site and the substrate, ensuring that only substrates with the correct three-dimensional arrangement can bind effectively. This demonstrates the fundamental role of chirality in the molecular machinery of life, underscoring the importance of stereochemistry in understanding biological systems and designing therapeutic agents.

Chirality is of paramount importance in drug design and pharmacology because the biological activity of drug molecules is often highly dependent on their three-dimensional configuration. Many drugs are chiral, and the two enantiomers of a chiral drug can have markedly different effects in the body. One enantiomer may be therapeutically active, providing the desired biological effect, while the other may be inactive or even harmful. This enantiomeric specificity arises because biological targets, such as enzymes and receptors, are themselves chiral and thus exhibit a preference for interacting with one enantiomer over the other. Recognising this, pharmaceutical research and development increasingly focus on the synthesis and use of enantiomerically pure compounds, known as enantiopure drugs, to maximise therapeutic efficacy and minimise side effects. This has led to the development of chiral separation techniques and asymmetric synthesis methods that allow for the production of enantiomerically pure drugs, illustrating the critical role of chirality in modern pharmacology.

Determining the absolute configuration of a chiral molecule involves elucidating the spatial arrangement of its atoms, specifically which direction the chiral centres rotate plane-polarised light. The most direct method is X-ray crystallography, which provides a three-dimensional image of the molecule, revealing the orientation of its atoms and thus its chirality. Another common approach is the use of chiral reagents or derivatisation agents that react with the chiral molecule to form diastereomers, which have different physical properties and can be separated and analysed. Additionally, optical rotation measurements using a polarimeter can give insights into the chiral nature of the molecule, but without correlation to known standards or additional chiroptical techniques like circular dichroism, this method cannot unambiguously determine absolute configuration. Advanced spectroscopic methods, such as NMR spectroscopy using chiral shift reagents, can also provide information about the three-dimensional arrangement of atoms in a chiral molecule. These techniques, often used in combination, allow chemists to accurately determine the absolute configuration of chiral molecules, which is crucial for understanding their chemical behavior and biological activity.